• Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
PsyNews.com
  • Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Home Featured Page 270

Featured

Latest
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

Does Cannabis Research Deserve As Much Funding As Ibogaine Research?

Pα+ Psychedelic Bulletin #201: Dispatches from Prague and London; Texas Becomes Leader in Ibogaine Research as Governor Signs $50M Match-Funding Bill; High-Dose LSD Shows...

May 2025 Psychedelic Patent Update: Gilgamesh Broadens Moat Around Lead Candidate Following Positive Phase 2a Readout; Lykos Publishes Further Continuation Applications; Reconnect Joins Crowded...

Win 10 Groundbreaking Psychedelic Books – Our Giveaway with Inner Traditions!

Psychedelic Playhouse by District216

Online Psychedelic Community Options to Ride Out the Rest of Covid-19

Psychedelic Bulletin: Field Trip Raising $83m; NYU Langone Launches Psychedelic Medicine...

MindMed Closes Acquisition of HealthMode, a Leading Machine Learning Digital Medicine...

MindMed Closes Acquisition of HealthMode, a Leading Machine Learning Digital Medicine...

Purging the Pain: Hurting As Healing

Field Trip Health Announces Upsize to Previously Announced Bought Deal Public...

Psychedelic Business News Spotlight: February 26, 2021

California State Senator Introduces Bill to Decriminalize Psychedelics

Psilera Bioscience Obtains DEA Approval to Conduct Cutting Edge Psychedelics Research

PTSF48 – Decriminalization, Embracing the Mystical, and a Plea for More...

1...269270271...289Page 270 of 289

EDITOR PICKS

Does Cannabis Research Deserve As Much Funding As Ibogaine Research?

Pα+ Psychedelic Bulletin #201: Dispatches from Prague and London; Texas Becomes...

May 2025 Psychedelic Patent Update: Gilgamesh Broadens Moat Around Lead Candidate...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY

    ABOUT US
    PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.
    FOLLOW US
    ©